Non‐Hispanic Whites have the highest incidence rate of ovarian cancer in the U.S. Current surveillance strategy, by trans‐vaginal ultrasound and serum tumour marker cancer antigen 125 (CA125), is ineffective in detecting ovarian cancer at an early stage 2, 3. This evidence concerns the gene MUC16 and ovarian carcinoma.